Stay up to date with the latest breaking news, analysis and commentary on Mirae Asset Sharekhan. Find live updates, exchanges, stock news, earning news and more.
The company has received an appellate order upholding a tax demand of Rs. 984 crore, the insurance informed in an exchange filing. The Commissioner of CGST and Central Excise (Appeals-III), Mumbai, dismissed its appeal at 9:15 AM on Thursday, thereby sustaining the tax demand originally raised under Form GST DRC-07. The demand pertains to the reversal of input tax credit under the GST law for the period from July 2017 to July 2022. Negative
ICICI Pru Life (₹ 651.3 0.41% )
20 Feb 2026, 3:13PM
Stock update: Jyothy Labs Q3FY26 (Consolidated) result update – Margins drag Q3; outlook cautious
Jyothy Labs (₹ 246.05 2.55% )
20 Feb 2026, 11:20AM
Paras Defence acquired 49% equity stake in Himanshi Thermal Solutions on February 19, 2026. Himanshi Thermal operates in aerospace and defence engineering, specializing in fabricated metal products and liquid cold plates for space applications. - The company also provides vacuum heat treatment services. - Himanshi Thermal reported nil turnover in FY 24-25 and a PBT of Rs. -8,88,700, with losses over the past three years.
Paras Defence (₹ 642.15 1.89% )
20 Feb 2026, 10:25AM
Federal Bank: The bank is due to receive a tax refund of ₹686 crore after the successful resolution of a long-standing tax matter, it announced Thursday. The refund is related to the assessment years - AY 2011-12, AY 2012-13 and AY 2013-14, including interest. Positive
Federal Bank (₹ 292.6 1.49% )
20 Feb 2026, 10:19AM
Zydus Lifesciences: The company received a major win as its Unit 9 facility in Ahmedabad successfully passed a US FDA inspection for injectable medical devices. The inspection, which concluded on February 19, 2026, had zero observations, signalling strong compliance. This is a significant positive for the company's injectable business, potentially paving the way for smoother market access and approvals for its products manufactured at this site. This development comes after the company has been working to bolster its regulatory standing. Positive
Zydus Lifesciences (₹ 900.75 -0.18% )
20 Feb 2026, 10:18AMTWEETS BY @Sharekhan
